Replies to post #21 on Cumberland Pharmaceuticals, Inc. (CPIX)

[surf1944]

CPIX: Drug/indication:Acetadote for non-acetaminophen acute liver failure
Approval decision date: December 2010
Recent stock performance: At $4.92, stock is trading at its lows for the year.
The FDA review was extended three months beyond its original August approval date.

http://www.thestreet.com/story/10847027/6/21-drugs-facing-fda-approval-decisions.html